chrisvoncsefalvay/vaers-outcomes huggingface dataset:
For the last several years, I've had occasional pain in my right knee. After my second booster, the knee pain has increased; For the last several years, I've had occasional pain in my right knee. After my second booster, the knee pain has increased; It's been keeping me awake at night and still lingers today (18 days later); I developed pain in my left shoulder and left side of my neck (my shot was in my left shoulder).; I developed pain in my left shoulder and left side of my neck (my shot was in my left shoulder).; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 24May2022 as dose number unknown (booster), single (Lot number: FM0173) for covid-19 immunization. The patient's relevant medical history included: "pain in my right knee" (unspecified if ongoing), notes: For the last several years, I've had occasional pain in my right knee. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose number -1, Manufacturer unknown), for covid-19 immunization; Covid-19 vaccine (Dose number -2, Manufacturer unknown), for covid-19 immunization; Covid-19 vaccine (Dose number -3, Manufacturer unknown), for covid-19 immunization. The following information was reported: ARTHRALGIA (non-serious), NECK PAIN (non-serious) all with onset 28May2022, outcome "unknown" and all described as "I developed pain in my left shoulder and left side of my neck (my shot was in my left shoulder)."; CONDITION AGGRAVATED (non-serious), ARTHRALGIA (non-serious), outcome "unknown" and all described as "For the last several years, I've had occasional pain in my right knee. After my second booster, the knee pain has increased"; MIDDLE INSOMNIA (non-serious), outcome "unknown", described as "It's been keeping me awake at night and still lingers today (18 days later)". Therapeutic measures were taken as a result of arthralgia, neck pain, condition aggravated, arthralgia.  Additional Information: Patient never had a reaction to a Pfizer Covid shot until patient had 2nd booster on 24May2022. About four days after the second booster (Lot # FM0173), developed pain in left shoulder and left side of neck (shot was in patient left shoulder). It's been keeping patient awake at night and still lingers today (18 days later). Tylenol seems to help reduce the pain. For the last several years, patient had occasional pain in his right knee. After second booster, the knee pain has increased.
Left upper arm with 10 x 12 cm raised, warm, erythematous, indurated. Patient was treated for a cellulitis with AUGMENTIN, warm compress.
Small pox vaccine 9/13, reading major reaction 9/20, 9/21 developed chills body aches, localized streaking from small pox site to left axilla. Received z-pack. Follow up visit 9/27: resolved cellulitis: scab formation present
13 month old in for WCC. Was given both MMRV and Varicella vaccine. Age of patient at time of event: 1 years 1 months. Type of Event: Extra dose. Contributing factors: inattention to detail of vaccine prep and admin.
Day 8 I woke up the injection spot felt tender and sore again. I noticed the spot was red, warm, a little itchy and swollen around the injection site.
severe flu w/aches/pains, fever, exhaustion, phlegm;zithromax;cleared color of phlegm;
I experienced numbness and a pins and needles type feeling in both arms and legs.  The numbness in the legs lasted for approximately two weeks.  The numbness in the arms lasted for approximately three months. My left arm was the worst.  I had problems with it going numb and pins and needles feelings all through the day and night for three months.  My primary care doctor, , referred me to a neurologist.  During that appointment, a staff member tested my arm with a pin to see if I could feel it.  I felt the pin, but I was not experiencing numbness at the time.  I left without any further testing.  I went to a chiropractor at the end of March 2021, and I am presently still having treatments.  He stated that I have a herniated disk in my neck. I have not had problems with my neck in the past.  I am better now and not having any numbness.
My previous mild tinnitus increased the following day, became louder and more noticeable but still mild. Headaches, pressure around skull and behind ears, feeling of fullness and stuffiness in both ears. Symptoms would increase and lessen throughout the day, daily, over the following week. Seven days after injection an itchy rash and soreness presented at injection site on arm. For tinnitus I increased vitamin C and fluids, symptoms remain and vary during the day.
Tongue started tingling approximately 10 minutes after receiving vaccine. Patient states it felt like something was on her tongue, like thrush (patient states she has a history of having thrush). Patient was observed for a total of 30 minutes after vaccination and a nurse practitioner on site noted the patient's tongue appeared white posteriorly and midline. Patient contacted her doctor that evening and given the description and patient's history of thrush, he prescribed fluconazole 150 mg tablets once daily for 7 days to treat thrush. Patient reports she also took Tylenol 500 mg the night after receiving vaccine.
Headache, Arthralgia, NauseaVomiting, Chills Narrative:
On the day of vaccination I was treated at the site for a reaction which started 40 minutes after the shot. I was hypertensive and Tachycardia and I had chest tightness . I was monitored for 90 minutes and I had taken some Prednisone and they gave me Allegra. I left there and six hours later I felt worse. I had been having intermittent chest pain. My chest pain got worse and my heart rate was elevated so I went the ED. I was given Benadryl and Pepcid. I was discharged after two hours but I still had some chest pain. I took another dose of Steroids after four days I felt better.  I have a scheduled Stress Test at Hospital for follow up. I still have some burning chest pain on occasion.
Sterile abcess @ site of injection.  Negative Gram stain Negative Culture.
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced headache and pain in arm. On an unknown date, the outcome of the headache and pain in arm were unknown. It was unknown if the reporter considered the headache and pain in arm to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. After vaccination, the patient experienced mild headache and a sore arm. The patient got vaccination at pharmacy but did not remember the pharmacist who gave her the shot. For tolerance to next dose, refer case US2018GSK232226.
12/24/2022, I started to feel feverish, had a sinus headache and congestion. On 12/26/2022, my COVID-19 test was positive at home. I went to urgent care and test positive there. I was ill for a week to ten days, mostly managing the coughing and fatigue. I am still testing positive.
Varicella Information has been received from a physician and a school nurse concerning a 11 year old male who on 31-MAY-1995 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck).  It was also noted that the child was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) on 29-AUG-1995 and 10-JUN-1998. A school nurse reported to the physician that between 24-MAR-2005 and 09MAY-2005, the child developed a "more severe case" of chickenpox, noted to be breakthrough with 50 to 250 lesions. Unspecified medical attention was sought. The outcome was recovered. A product quality complaint was not involved. No additional information is expected.
About 2 or so hours after getting the vaccine shot I started developing sharp needles pains in my hands and feet. This affect was so severe I wasn?t able to sleep for two days before deciding to go to the ER. I was admitted and kept in the hospital for three days but was made to feel like it wasn?t anything major. I?m not sure what they final hospital files said but was talked to about neuropathy and was given a prescription of neurotin. The level of pain has decreased to a degree but still remains over a month later with sharp needle pains in my hands and feet and when it flares up I can even feel it in my face.  I have been feeling fine and healthy for years, these symptoms were developed directly after receiving the vaccine. There is no doubt in my mind what I?m suffering from was a result of getting the vaccine. Did
I experienced injection site/ arm pain, my arm became hot, red, itchy and swollen. I felt very fatigued, headache, felt feverish, nauseous, my eyes had a burning sensation, under my right breast 2 patches itchy hives developed. When I would try to get up out of bed to go the restroom. I would become tired and out of breathe just from that effort. I would also become weepy after several hours of the fatigue, and it was not an experience I've had previously. I do believe the vaccine was also affecting my moods. These symptoms persisted for 4 weeks before resolving. These symptoms returned on my trip after I was exposed to a positive COVID-19 case, and the fatigue was not as severe as the adverse event 2 days after vaccination. I tested negative for COVID-19 prior to returning from traveling. 2 days after returning, I began experiencing symptoms of severe fatigue, chills, brain fog, nausea, headache, myalgia, the 2 patches of hives returned and these symptoms have become recurrent with new symptoms of palpitations and chest pressure. The symptoms have been reoccurring at random intervals, and I am seeking ongoing care for my symptoms. My new PCP, there has not been a diagnosis as of yet, and I have not recovered from my adverse event. I have begun taking baby aspirin and some of the symptoms/frequency/duration have become much less severe. Several weeks ago I began experiencing a new symptom of joint pain in my hips, left knee, shoulders, right thumb, right hand to the point I have difficulty making a fist, elbows, and it has escalated in a matter of weeks. At the same time, the joint pain began my eyes started burning again, the hives became itch again, my short term memory has been failing frequently i.e. burned a kettle and left home without my slippers, and took the wrong road to go to the grocery store which are parts of my day to day routine. I am still weepy as in emotional swing with feelings of vulnerability and almost paranoid suspicious thoughts.
This case was reported by a consumer and described the occurrence of drowsiness in a 18-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. There were no concurrent medications. On 13 June 2012 at 13:00 the subject received 1st dose of CERVARIX. On 13 June 2012, immediately after vaccination with CERVARIX, the subject experienced drowsiness, nausea, almost fainted and tiredness. At the time of reporting the events were unresolved.
NEEDLE MALFUNCTION . LEAKAGE  FROM NEEDLE. NOT SURE HOW MUCH PATIENT RECEIVED. DID NOT REPEAT DOSE
It nearly killed me; The patient received influenza vaccine and Fluad Quadrivalent; This spontaneous case was received on 26-Apr-2021 from other non-health professional (consumer) via Media Communication (reference number: SEQW21-01242) and concerned female patient, of an unreported age.  The patient's medical history and concomitant medications were not reported.   On an unknown date, the patient was vaccinated with influenza virus vaccine polyvalent (brand not specified; dose, route of administration and anatomical location; not reported) as prophylactic vaccination. The batch number was not reported.   On an unknown date, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; dose, anatomical location and route of administration: not reported) (explicitly coded as 'Extra dose administered') as prophylactic vaccination. The batch number was not reported.  On an unknown date, unknown amount of time after receiving influenza virus vaccine polyvalent and Fluad Quadrivalent, it nearly killed the patient (as reported).    The outcome of the event 'near death experience' was unknown.   The reporter assessed the event as related to Fluad Quadrivalent and influenza virus vaccine polyvalent.  The event of 'near death experience' was considered to be medically significant by a Physician within Seqirus' Pharmacovigilance and Risk Management Department.  Company comment: A patient of an unreported age was vaccinated with Fluad Quadrivalent. On an unknown date, the patient was vaccinated with influenza virus vaccine polyvalent. On an unknown date, unknown amount of time after receiving influenza virus vaccine polyvalent and Fluad Quadrivalent, it nearly killed the patient (as reported). Causality is unassessable for near death experience due unclear information regarding event, temporal relationship, medical history and diagnostic findings. Extra dose administered is assessed as not related per company's conventions.; Reporter's Comments: It nearly killed the patient.; Sender's Comments: A patient of an unreported age was vaccinated with Fluad Quadrivalent. On an unknown date, the patient was vaccinated with influenza virus vaccine polyvalent. On an unknown date, unknown amount of time after receiving influenza virus vaccine polyvalent and Fluad Quadrivalent, it nearly killed the patient (as reported). Causality is unassessable for near death experience due unclear information regarding event, temporal relationship, medical history and diagnostic findings. Extra dose administered is assessed as not related per company's conventions.
Patient stated that her arm is still sore over one month since vaccine was administered. She states it is not excruciating and may actually be getting better. She described it as a possible muscle pain when lifting her arm.
26 Patient received a expired vaccine 16Apr2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (26 Patient received a expired vaccine 16Apr2022) in a 59-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 007J21-2a) for COVID-19 vaccination.     Other vaccine was not given to the patient within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Penicillin allergy (Penicillin), Diabetes and Heart disease, unspecified.    On 20-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (26 Patient received a expired vaccine 16Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (26 Patient received a expired vaccine 16Apr2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The treatment information was unknown.
Subject was vaccinated with ACAM 2000 on June 2, 2011.  On June 10, 2011 subject presented for follow-up.  At that time she had a major take reaction to the ACAM 2000.  She had a large amount of erythema and edema around the vaccination site.  Subject was encouraged  to take ibuprofen as needed if her symptoms progressed.  Subject's  symptoms did worsen, despite taking ibuprofen.  On the evening of June 11, 2011 subject developed chest pain and dyspnea.  These symptoms persisted and progressed on June 12, 2011.  On the morning of June 13, 2011 she was seen in clinic.  Subject had a low grade fever with sinus tachycardia, chest pain and dyspnea on exertion.  She was also noted to have supraclavicular nodes with pain and edema and erythema.   The chest pain and dyspnea were severe enough that she was evaluated for possible myocarditis and pericarditis at the local hospital emergency room.  Fortunately, her evaluation ruled out pericarditis and myocarditis but did suggest that perhaps on CT she had mild pneumonitis.  While the Emergency Room clinician prescribed a short course of azithromycin 500 mg x 3 days, this clinician is of the opinion that this adverse event is probably vaccine related.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX lot # N000683 or lot # N002204 for prophylaxis.  Concomitant therapies included sterile diluent (DILUENT MRK). No adverse effects were reported. This is one of two reports received from the same reporter; Sender's Comments: US-009507513-1708USA007526:
Completed the course of Vivotif in an inappropriate schedule as she took the second dose of vivotif on day 5; Spontaneous report received on 26DEC2020.  A 43-year-old adult female consumer reported that she "missed her second dose of Vivotif" (PT: Product dose omission issue). She was receiving Vivotif (lot number: 3003330 and expiry date: DEC2020) for immunisation for typhoid. On 22DEC2020, she took her first dose of Vivotif. On 26DEC2020, she reported that she missed to take her second dose of Vivotif. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer missed her second dose of Vivotif (missed dose) on the scheduled date. Further details of the event is limited. Vivotif doses should be taken every other day. Considering the nature of the event, the causality of missed dose is not applicable to Vivotif.  Follow up information was received on 05JAN2021. Previously reported event was updated.  It was reported that the consumer "Completed the course of Vivotif in an inappropriate schedule as she took the second dose of vivotif on day 5" (PT: Inappropriate schedule of product administration). On 26DEC2020, she took her second dose of Vivotif and took her third and fourth dose of Vivotif on 28DEC2020 and 30DEC2020 respectively. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: It was reported that a consumer completed the course of Vivotif in an inappropriate schedule as she took the second dose of vivotif on day 5 (Inappropriate schedule of product administration). This consumer missed her second dose of Vivotif on the scheduled date and took it on day 5 instead of day 3, and then completed the remaining course. Vivotif doses should be taken every other day, and considering the nature of the event, the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif. ; Sender's Comments: It was reported that a consumer completed the course of Vivotif in an inappropriate schedule as she took the second dose of vivotif on day 5 (Inappropriate schedule of product administration). This consumer missed her second dose of Vivotif on the scheduled date and took it on day 5 instead of day 3, and then completed the remaining course. Vivotif doses should be taken every other day, and considering the nature of the event, the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif.
pt came to clinic c/o redness & swelling (3 1/2" x 2 1/2" area) approx 2" above lt elbow;flu vax should have been given in deltoid muscle;appeared to have been given in SQ tissue;pt stated area itched & a little painful;advised to see
Patient signed up for COVID vaccine online and was administered Pfizer COVID vaccine first dose. After administration, patient said that he did not want Pfizer brand and wanted Moderna. Patient did not experience any adverse affects from Pfizer as of yet.
pt recv vax 12SEP97 lt arm became hard, red, hot, sore;noticed on evening of 13SEP97;seen on 15SEP97 local redness warmth;pt mom states now less red;
maculopapular rash x 5 days;fever, cough, coryza & joint pain;
Information was received on 09-JUL-2018 from a lawyer regarding a case in litigation. A female patient, age unspecified, was inoculated with ZOSTAVAX on 22-MAY-2012 at a medical clinic as recommended for routine adult health maintenance for prevention of shingles. It did not prevent shingles as intended and subsequently the patient contracted a persistent strain of herpes zoster. In 2014  the patient was treated by a physician at a medical clinic for a blistering vesicular outbreak which was then diagnosed as herpes zoster,  or shingles. As a direct and proximate result of ZOSTAVAX or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Additional information has been requested.
Headache, muscle aches, joint aches, photophobia, pain at site (arm pain), and fatigue
Positive test for Covid 8/26/2022 with symptoms beginning 8/23/2022
This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 14-JUL-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # of L003188 and an expiration date of 06-JUL-2016 (route and anatomical location of administration were not reported). The sum of hours in excursion were 64 hours and the lowest recorded temperature reported were 31 and 34 Fahrenheit (F) -0.555555556 and 1.111111111 Celsius (C)) respectively. The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Widespread macular examthem. Temp of 100.7. Dizzy, tired, headache, and nausea. No treatment required.
Hives and rashes all over body. I?m taking 50mg of Benadryl every 6 hours to control it.
Increased heart rate. Fluctuations of heart rate. Fatigue. Slight pressure in chest and left pectoral area at times.
mild case of Shingles/suspected vaccination failure; mild case of Shingles 2 weeks ago; This case was reported by a nurse via sales rep and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. In May 2022, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with acyclovir (Aciclovir). On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date: 17-May-2022 Reporter's comment: The patient was vaccinated with both the doses of Shingrix but presented with a mild case of Shingles 2 weeks ago from reporting date. The patient provided a script for Aciclovir and told to contact office if shingles did not clear up. Nurse practitioner had not heard back from the patient. The reporter did not consent to follow-up. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.